The gross margin of 64.9% has also been in line with expectations, reflecting the impact of the high cost of production goods and inflation that has...
Gilead Sciences had $6.4 billion in revenue in the first quarter of 2023, a 4% year-over-year decrease from the same period a year earlier. The company...
Better works with healthcare professionals to determine which type of medications are best for patients, after having analyzed and parameterized their data. The company's platform, Better Meds, provides...
Docline maintains an agreement with Mapfre, with whom it offers digital health programs to the company's policyholders; with the Ballesol retirement home company, to whose patients it...
Sysmex's investment in Spain in the last three years has exceeded $10.7 million (10 million). During that period, the company has hired a hundred workers. The main...
Medendi has been active since February 2021 and has received over 1,500 requests for support from Italian cancer patients. The year 2023, thanks to the injection...
Currently, Fertty performs 1,000 treatments a year, a figure it expects to double in a matter of three years. Fertty closed 2020 with a turnover of...
The company has offices in Madrid, Barcelona and Mexico, the latter covering several Latin American countries. To date, iDoctus has invested $5.9 million (€5 million) in...
The Spanish biotech company Prim has recently published its first quarter financial results. The company has reduced its revenues by 3.1%, to $45 million (€37.2 million)....
Grifols' gross operating profit (Ebitda) was $356.4 million (€296.8 million) compared to $421 million (€351 million) in the first quarter of 2020 and accounted for 25.1%...